Selective mutism and obsessive compulsive disorders associated with zonisamide

Seizure

Volumn 11, Issue 7, 2002, Pages 468-470

  Hirai, Katsuaki ^a,b   Kimiya, Satoshi ^a,b   Tabata, Koji ^b   Seki, Tohru ^a   Jozaki, Keiji ^a,c   Kumagai, Noboru ^a  

^a KEIO UNIVERSITY   (Japan)

^b Shimada Ryouiku Centre   (Japan)

^c Hiratsuka Kyosai Hospital   (Japan)

Author keywords

Adverse effects; Behaviour disturbance; Epilepsy; Obsessive compulsive disorders (OCD); Selective mutism; Zonisamide

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ZONISAMIDE;

ADOLESCENT; ANTICONVULSANT ACTIVITY; ARTICLE; BEHAVIOR DISORDER; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPULSIVE PERSONALITY DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; MALE; MENTAL DISEASE; MUTISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SYMPTOMATOLOGY; TONIC CLONIC SEIZURE; VIOLENCE;

EID: 0036796755     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0625     Document Type: Article

References (11)

1. Wilensky, A. J., Friel, P. N., Ojemann, L. M., Dodrill, C. B., McCormick, K. B. and Levy, R. H. Zonisamide in epilepsy: a pilot study. Epilepsia 1985; 26: 212-220.
2. Miyamoto, T., Kohsaka, M. and Koyama, T. Psychotic episodes during zonisamide treatment. Seizure 2000; 9: 65-70, doi: 10. 1053/seiz. 1999.0368.
3. Kimura, S. Zonisamide-induced behaviour disorder in two children. Epilepsia 1994; 35: 403-405.
4. Toone, B. Psychoses of epilepsy. In: Epilepsy and Psychiatry (Eds E. H. Reynolds and M. R. Trimble). London, Churchill Livingstone, 1981: pp. 113-137.
5. Kumagai, N., Seki, T, Yamawaki, H. et al. Monotherapy for childhood epilepsies with zonisamide. Japanese Journal of Psychiatry and Neurology 1991; 45: 357-359.
6. Mimaki, T., Mino, M., Sugimoto, T. and Murata, R. Antiepileptic effect and serum levels of zonisamide in epileptic patients with refractory seizures.. In: Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology (Ed. I. Sunshine). New York, Marcel Dekker, 1992: pp. 437-442.
7. Mimaki, T. Clinical pharmacology and therapeutic drug monitoring of zonisamide. Therapeutic Drug Monitoring 1998; 20: 593-597.
8. Kochak, G. M., Page, J. G., Buchanan, R. A., Peters, R. and Padgett, C. S. Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures. The Journal of Clinical Pharmacology 1998; 38: 166-171.
9. Koopowitz, L. F. and Berk, M. Response of obsessive compulsive disorder to carbamazepine in two patients with comorbid epilepsy. Annals of Clinical Psychiatry 1997; 9: 171-173.
10. Taira, T. Zonisamide induced tremor-report of two cases. No To Shinkei 1992; 44: 61-63.
11. Trimble, M. R., Rusch, N., Betts, T. and Crawford, P. M. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables. Seizure 2000; 9: 249-254, doi: 10.1053/seiz.2000.0405.